Human insulin: a biotechnological scapegoat?
Miller
J J
JJ
Novo Nordisk Pharmaceuticals Pty Ltd, North Rocks, N.S.W.
Colagiuri
S
S
D000818:Animals; D001364:Awareness; D001709:Biotechnology; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013552:Swine
D007328:Insulin; D011994:Recombinant Proteins